Cochrane's first open access journal launched today
Cochrane’s first ever open access journal, Cochrane Evidence Synthesis and Methods, has opened for submissions today.
‘Cochrane Evidence Synthesis and Methods strengthens Cochrane’s ability to publish diverse types of evidence synthesis, methods research, and research on other areas vital to evidence synthesis,’ explains the new journal’s Editor, Michael Brown. ‘The journal provides a platform for disseminating research beyond systematic reviews from across Cochrane groups and collaborators, who until now, have not been able to publish their research in a Cochrane journal.
‘We can collaborate more closely with guideline developers, decision makers and funders through publication of evidence syntheses directly relevant to their specific interests. We hope the community is as excited as we are to be able to publish a journal underpinned by Cochrane’s philosophy for transparency, integrity, and independence.’
Working in conjunction with Cochrane’s publisher, Wiley, this journal strengthens Cochrane’s ability to meet diverse stakeholders’ needs and publish different types of evidence synthesis beyond systematic reviews. It will include methods research evaluating how evidence syntheses is planned, produced and disseminated, and feature research articles on critical areas for evidence synthesis, such as priority setting, consumer involvement and research integrity.
Cochrane has over 100,000 members and contributors globally who publish their systematic reviews in the Cochrane Library. Our new journal opens up opportunities for these members, along with researchers who are new to Cochrane. The journal aims to further develop the evidence base for how we produce and publish evidence synthesis, share best practice, case studies and commentaries.
‘This is an exciting milestone for Cochrane,’ says Editor in Chief Karla Soares-Weiser. ‘Cochrane Evidence Synthesis and Methods enables us to publish a wider range of evidence products that meets a more diverse range of stakeholder needs. It will ensure Cochrane can better respond to important global health and social care needs and influence health decisions that go beyond the remit of systematic reviewing alone.’
‘Cochrane Evidence Synthesis and Methods welcomes innovative ideas and is not afraid to trial new ways of publishing,’ adds Ella Flemyng, Cochrane’s Editorial Product Lead. ‘This includes showcasing practices that support research integrity, embedding consumer involvement within the journal, piloting how to better visualise research, and improving peer review.’
For more information: